Neurologic in Medical Technology

Pennsylvania Agriculture Department Issues Quarantine for Allegheny County Horse Stable

... at least three horses tested positive for the neurologic form of Equine Herpesvirus, or EHV-1, Agriculture ... symptoms in several horses consistent with the neurologic form of EHV-1 and alerted the Bureau of Animal ... Services on July 19. Symptoms of the neurologic form of EHV-1 include loss of coordination, ...

Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting

... improvements were seen in neurologic examination using the Neurological Impairment ... and motor nerves. Specifically, improvement in neurologic evaluation by NIS-LL in SB-509-treated subjects ... as reflex testing and is a quantifiable score of neurologic exam. These three measurements have all been used ...

Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest

... body-cooling treatment in three cases - and each patient showed remarkable neurologic recovery. Therapeutic hypothermia treatment, where cardiac arrest ... we've had three patients who have had complete recovery of neurologic function after prolonged cardiac arrest," said G. Scott Brewster, M.D., ...

Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack

... injuries such as tissue damage following a heart attack or adverse neurologic outcomes. Numerous scientific and medical articles have described the ... three hours of onset, many stroke patients continue to suffer advanced neurologic damage even though they have received tPA. More importantly, most stroke ...

AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria

... to an accumulation of toxic intermediate metabolites resulting in a wide variety of problems including acute, severe abdominal pains, psychiatric, neurologic illnesses, and muscular weakness. Long-term consequences may be irreversible nerve damage, liver cancer and kidney failure. Acute porphyric attacks ...

Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy

... with the signing of an agreement to license a new drug for the treatment of narcolepsy, a chronic and debilitating sleep disorder, as well as other neurologic and psychiatric conditions. The agreement to license ADX-N05 gives Addrenex the worldwide rights (excluding East Asia) to develop, manufacture ...

Adding Steroid Drug to MS Treatment May Reduce Disease Activity

... an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. For more information about AAN, visit www.aan.com . The AAN 61st Annual Meeting, takes place April 25 - May 2, 2009, in Seattle. ...

For Iraq Veterans, Headaches Continue After Traumatic Brain Injury

... an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as ...

Young Smokers Increase Risk for Multiple Sclerosis

... an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as ...

Can Exercising Your Brain Prevent Memory Loss?

... an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as ...

Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

... with AD are institutionalized. There is a significant need for sleep medications that improve sleep quality in patients with neuropsychiatric and neurologic disorders and comorbid sleep disorders. ABOUT ITI-007 ITI-007 is the Company's first-in-class dual 5HT2A receptor antagonist/dopamine ...

Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder

... per 100 years compared with an incidence of 0.06 per 100 years, respectively). In the pre-TCD group, 21 patients had overt stroke, three had other neurologic events, and two experienced indeterminate events. The post-TCD group had two patients who experienced overt stroke, six with other neurological ...

Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment

... candidiasis, bacterial infection (including urinary tract infections), upper respiratory infection, dizziness (including vertigo), headache, neurologic sensation disorders (including paraesthesias), cough, nasopharyngeal pain, diarrhea, abdominal pain, stomatitis and mouth ulceration, nausea, hepatic ...

Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkin's Lymphoma

... from lung cancer. A previous phase 3 trial showed that the addition of MGd to whole brain radiation therapy (WBRT) improved the median time to neurologic progression from 10.0 months to 15.4 months (P=0.12). At the 2007 American Society of Clinical Oncology Annual Meeting (ASCO), Pharmacyclics ...

Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil

... airway disease, sleep apnea, and enlargement of the liver and spleen. In some cases, central nervous system involvement leads to progressive neurologic decline. Shire Human Genetic Therapies is actively tracking health data among individuals affected by Hunter syndrome as part of the company's ...

Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children

... Administration of a Serotype 2 Adeno-associated virus expressing the CLN2 cDNA," the authors report that over an 18-month period, assessment using a neurologic rating scale demonstrated significant slowing of disease progression in the treated, compared to the untreated children. On the basis of these ...

Steroids Provide No Survival Benefit for Children With Bacterial Meningitis

... commonly caused by pneumococcal or meningococcal bacteria. Further studies may reveal that corticosteroids may also reduce hearing loss or other neurologic injuries in children with bacterial meningitis not caused by Hib, said Shah, but there is currently no such evidence. He added, "Our study shows the ...

EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia

... is Chief Executive Officer and Medical Director of the CRI which specializes in early clinical pharmacology studies in patients with psychiatric and neurologic diseases. Dr. Preskorn is also a Professor in the Department of Psychiatry and Behavioral Sciences at the Kansas University of School of Medicine - ...

Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia

... and post-menopausal women, and in other disorders where insomnia is a problem, including osteoarthritis, depression, Parkinson's disease and other neurologic and psychiatric disorders." The Phase 2 program is a multi-center, randomized, double-blind placebo- controlled study in patients with SMI. The ...

BioMarin Announces FDA Approval for Kuvan

... for this indication. Important Safety Information Prolonged exposure to elevated blood Phe levels in PKU patients can result in severe neurologic damage. The initiation of Kuvan therapy does not eliminate the need for careful monitoring of blood Phe levels and ongoing dietary management. Some ...

Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke

... are intended for the treatment of a serious or life-threatening condition. The Phase 2 CARNEROS-1 (Catheter Directed Alfimeprase for Restoration of neurologic Function and Rapid Opening of Arteries in Stroke) proof-of-concept trial is a multi-center, open-label, two part, dose escalation (1 mg, 5 mg and 10 ...

Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoit's Brain

... member, Robert Cantu, MD, Chief of Neurosurgery Service and Director of Sports Medicine at Emerson Hospital in Concord, MA, and Co- Director of the neurologic Sports Injury Center at Brigham and Women's Hospital in Boston, MA. Chronic Traumatic Encephalopathy (CTE) is a form of brain damage that is best ...

Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

... no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. (1) Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52. (2) Rio J, Nos C, Tintore M, Tellez N, ...

Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting

... The results indicate that at least 1.8 million neurologic patients in the U.S. suffer from frequent and ... from patients with IEED, secondary to various neurologic diseases or injuries, treated with Zenvia for 52 ... profile based on age, sex, race or underlying neurologic disease; no treatment-related serious ...

New Data from the US and Japan Support: No Established Causal Link Between Neuropsychiatric Symptoms and Treatment with Tamiflu US Databases Indicate Psychiatric Symptoms Lower in Influenza Patients Taking Tamiflu Versus Those Not Taking Tamiflu

... March 20, 2007 -- Clinical studies have shown (1) similar rates of neurologic and psychiatric events in pediatric influenza patients being treated with ... Newland JG, Laurich VM, Rosenquist AW, Heydon K, Licht DJ, Keren R et al. neurologic complications in children hospitalized with influenza: characteristics, ...

Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting

... including an oral presentation of Phase 3 SMART (Study of neurologic Progression with Motexafin Gadolinium And Radiation Therapy) trial data. ... (MGd) combined with whole brain radiation therapy prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain ...

Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics

... with Surfaxin improved survival in preterm children, no differences in neurologic outcomes through one-year of life were observed between treatment groups, ... (p less than or equal to 0.05) reduction in two important assessments of neurologic outcomes (reflex abnormality and gross tone) versus Survanta. Robert J. ...

Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer

... whole brain radiation therapy (WBRT) has been shown to prolong time to neurologic progression in patients with brain metastases from NSCLC. The target for ... our NDA; because our Phase 3 clinical trial known as the SMART (Study of neurologic Progression with Motexafin Gadolinium And Radiation Therapy) trial failed ...

Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting

... in nerve health and includes assessment of several factors, including neurologic exam, QST, electrophysiologic studies and neurologic symptoms. In addition, data were presented from a subject with a ...

Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer

... of the study was overall survival. Secondary endpoints included response rate in the brain at three months, Karnofsky Performance Status, and neurologic signs and symptoms assessment. Conference Call The Company will host a conference call today at 8:30 AM ET. The dial in number for U.S. residents ...

Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer

... development of our pipeline; the possibility that the FDA refuses to approve our NDA; because our Phase 3 clinical trial known as the SMART (Study of neurologic Progression with Motexafin Gadolinium And Radiation Therapy) trial failed to meet its primary endpoint, the FDA may require additional data, analysis ...

Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

... + CR rate of 46 percent following SCT. * The VELCADE based therapy was well tolerated; the most common adverse events included neurologic toxicities, fever/infection and neutropenia. Patients on the VELCADE based therapy received four standard cycles of VELCADE at 1.3 mg/m2 on days ...

Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies

... self-limiting, it can be devastating in immunocompromised patients and occasionally precipitates serious complications that can include: coronary and neurologic infections, compromised respiration secondary to acute lymphadenopathy, anemia and ruptured spleen. Therefore, accurate diagnosis and prompt ...